The Latest Breaking News from Boston Scientific

Boston Scientific Expects to Miss Its 2026 Targets After a Cyberattack and Restores Cardiac Monitoring Signups

Boston Scientific says it will miss its 2026 sales and profit targets after a cyberattack. New cardiac remote monitoring sign-ups are working again.

Medical Daily · Sep 9

Boston Scientific Pulls Unused Spinal Cord Stimulator Leads Tied to Fractures, but Implanted Devices Stay in Place

FDA labeled Boston Scientific's Infinion CX lead removal a Class I recall after 1,081 serious injuries. Implanted leads are not affected.

Medical Daily · Sep 4

Heart Monitor Server Software Used by Boston Scientific Patients Draws Three Class 2 Recalls Over Delayed Alerts

FDA posted Class 2 recalls for Boston Scientific LUX-Dx monitor server software over delayed atrial fibrillation alerts. No injuries reported.

Medical Daily · Sep 3

Boston Scientific Says a Cyberattack Has Disrupted Systems Used to Process and Ship Medical Device Orders

Boston Scientific disclosed a cyberattack disrupting global systems including order processing and shipping, with no restoration timeline announced.

Medical Daily · Aug 27

Boston Scientific says cyberattack is causing a ‘global disruption’ to medical device operations

The company did not say what kind of attack it suffered, or when it might complete the restoration process.

TechRadar · Aug 27

FDA Issues an Early Alert on Boston Scientific Carotid Catheters After Reports of Tips Breaking Off

FDA issued an early alert on Boston Scientific ENROUTE carotid catheters after reports of arterial sheath tip separation during use.

Medical Daily · Jul 31

What Are Wall Street Analysts' Target Price for Boston Scientific Stock?

Boston Scientific underperformed the broader market, though analysts remain optimistic, citing strong earnings execution, innovation, and meaningful upside from current levels.

Barchart · Jul 30

Boston Scientific’s Quarterly Earnings Preview: What You Need to Know

Boston Scientific is gearing up for earnings day, weighing a rocky stock run against Wall Street's stubbornly optimistic outlook.

Barchart · Jul 2

Why These Three Big Buybacks Are Sending Very Different Signals to Investors

Quanta Services, Roblox, and Boston Scientific announced share buybacks totaling $6 billion, each under different market conditions and for different strategic reasons.

MarketBeat · Jun 1

Unusual Options Activity Points to Boston Scientific Stock as a Hot M&A Target

Boston Scientific posted two of the top three Volume-to-Open Interest ratios during Thursday's trading session, a notable signal often associated with heightened market speculation. This unusual options activity suggests the medical devices giant could be a potential acquisition target. Here's a closer look at why.

Barchart · May 29